Dinoprost (Prostaglandin F2α) 是一种口服有效的前列腺素 F (PGF) 受体 (FP receptor) 激动剂。Dinoprost 是在子宫内膜腔上皮和黄体 (CL) 中局部产生的溶酶激素。Dinoprost 在分娩过程中起关键作用。
生物活性 | Dinoprost (Prostaglandin F2α) is an orally active, potentprostaglandin F (PGF) receptor (FP receptor)agonist. Dinoprost is a luteolytic hormone produced locally in the endometrial luminal epithelium and corpus luteum (CL). Dinoprost plays a key role in the onset and progression of labour[1][2]. |
IC50& Target | Human Endogenous Metabolite | FP Receptor |
|
体外研究 (In Vitro) | Dinoprost (Prostaglandin F2α; 1 μM; for 24 hours) induces ER stress, autophagy, and apoptosis in goat luteal cells[1]. Dinoprost (1 μM; for 24 hours) significantly increases the expression of GRP78 and UPR sensors[1].
Apoptosis Analysis[1] Cell Line: | Goat luteal cells | Concentration: | 1 μM | Incubation Time: | For 24 hours | Result: | Significantly increased the apoptotic rate (15.62±3.12%). |
Cell Autophagy Assay[1] Cell Line: | Goat luteal cells | Concentration: | 1 μM | Incubation Time: | For 24 hours | Result: | There was extensive overlap between LC3 and LAMP1 in luteal cells and autophagolysosomes were formed in goat luteal cells. |
Western Blot Analysis[1] Cell Line: | Goat luteal cells | Concentration: | 1 μM | Incubation Time: | For 24 hours | Result: | The expression of GRP78 and UPR sensors including cleaved ATF6, phosphorylated-EIF2S1, EIF2S1, ATF4, phosphorylated-IRE1, autophagy-related protein LC3-II, and pro-apoptosis factor cleaved Caspase3 increased significantly in the cells. |
|
Clinical Trial | |
分子量 | |
性状 | |
Formula | |
CAS 号 | |
中文名称 | |
结构分类 | - Ketones, Aldehydes, Acids
|
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Pure form | -20°C | 3 years | | 4°C | 2 years | In solvent | -80°C | 6 months | | -20°C | 1 month |
|
溶解性数据 | In Vitro: H2O : 100 mg/mL(282.10 mM;Need ultrasonic) DMSO : 100 mg/mL(282.10 mM;Need ultrasonic) 配制储备液 1 mM | 2.8210 mL | 14.1052 mL | 28.2103 mL | 5 mM | 0.5642 mL | 2.8210 mL | 5.6421 mL | 10 mM | 0.2821 mL | 1.4105 mL | 2.8210 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: ≥ 2.5 mg/mL (7.05 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (7.05 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 2. 请依序添加每种溶剂: 10% DMSO 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (7.05 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (7.05 mM,饱和度未知) 的澄清溶液。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|